Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

Pioneering Technology Leads to First 3-Tesla, Cryogen-Free MRI Benchtop Scanner

By BiotechDaily International staff writers
Posted on 06 Mar 2013
Image: The new benchtop 3T MRI scanner (left) located near other laboratory equipment (Photo courtesy of MR Solutions).
Image: The new benchtop 3T MRI scanner (left) located near other laboratory equipment (Photo courtesy of MR Solutions).
Applying technological advances related to supercooling has enabled the development of a superior and more convenient 3-Tesla MRI scanner for biological and medical research laboratories.

The new “3T MRI” benchtop scanner, developed by MR Solutions (Guildford, UK), provides superior soft tissue contrast and molecular imaging capability as well as a breakthrough design that enables it to be conveniently fitted into an existing laboratory.

The scanner includes two major advances. First, the usual MRI liquid helium cooling system has been replaced by using a revolutionary magnet design incorporating new superconducting wire. Through a technology solution pioneered by MR Solutions and its magnet partner, this enables the use of a standard low-temperature cryocooler to cool the magnet to the 4 Kelvin required to achieve superconductivity. Second, the 3T MRI scanner does not require that it be isolated in a “Faraday cage” as its stray magnetic field is only a few centimetres and will not interfere with other equipment in a laboratory. The elimination of the helium cooling system has allowed an optimal installation of an additional solenoid to counter the stray magnetic field. These advances have also dramatically reduced the cost of this powerful scanner to make it highly competitive.

Professor Van der Linden from Bio Imaging Laboratory of the University of Antwerp commented, “This new scanner is a breakthrough and will provide us with the extra scanning power we need within our existing facilities. We can just wheel it in without knocking down any walls and without having to install a costly helium system and the safety system that goes with it. And as its stray magnetic field is so small, we can put other sensitive laboratory equipment and scanners close by for much better work flow.”

Related Links:
MR Solutions



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.